🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseHas anyone dealt with doctor said my fatty liver is gone - i literally cried? Page 4

Has anyone dealt with doctor said my fatty liver is gone - i literally cried?

MASHdoc_SA Mon, Feb 23, 2026 at 6:08 PM 33 replies 1,013 viewsPage 4 of 7
paige_pharma
Member
289
1,234
Sep 2024
Omaha, NE
Mar 4, 2026 at 10:07 AM#16

From the other side of the consultation, briefly. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

Last edited: Mar 4, 2026 at 11:07 AM
41 14rachel_ABQ, traveltech_sara, AttorneyGrant and 38 others
Reply Quote Save Share Report
tommy_boulder
Member
234
1,123
Nov 2024
Boulder, CO
Mar 5, 2026 at 6:44 PM#17

One thing that is still open after JennaRN’s answer:

How would you tell the difference between that and the alternative explanation?

Last edited: Mar 5, 2026 at 7:44 PM
42 15TinaHashiRN, robert_kc, dan_philly and 39 others
Reply Quote Save Share Report
kim_atl_prep
Member
312
1,345
Aug 2024
Atlanta, GA
Mar 7, 2026 at 3:21 AM#18
paige_pharma said:
The useful move here is to separate what is established from what is widely repeated.

This is where I part company with the consensus forming above. The objection nobody has made: this only works if the measurement is doing what we assume it is doing, and that assumption has not been tested here.

Correct me if the detail matters more than I have assumed.

43 16RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 40 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
JenPlateau
Member
234
890
Nov 2024
Missouri
Mar 8, 2026 at 11:57 AM#19
paige_pharma said:
The useful move here is to separate what is established from what is widely repeated.

Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.

44 17FitDadDave, RunnerRach, TrialNerd_Beth and 41 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Mar 9, 2026 at 8:33 PM#20

Moderator note: a couple of off-topic posts removed. Tagging this one for the weekly digest.

Last edited: Mar 10, 2026 at 12:33 AM
16 14PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 13 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register